Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Verve Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- +2 vs. Q4 2022
- Shares held
- 63.3M
- +646.5K (+1.0%) vs. Q4 2022
- Total value
- $911.8M
- −$300.1M (−24.8%) vs. Q4 2022
- New holders
- 21
- 42 more added
- Sold out
- 19
- 34 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 3 | $0 |
| Q1 2026 | 3 | $0 |
| Q4 2025 | 4 | $344.0K |
| Q3 2025 | 9 | $1.53M |
| Q2 2025 | 176 | $819.4M |
| Q1 2025 | 191 | $369.3M |
| Q4 2024 | 166 | $443.9M |
| Q3 2024 | 174 | $364.6M |
| Q2 2024 | 167 | $371.8M |
| Q1 2024 | 163 | $1.08B |
| Q4 2023 | 157 | $1.04B |
| Q3 2023 | 134 | $847.0M |
| Q2 2023 | 121 | $1.16B |
| Q1 2023 | 125 | $911.8M |
| Q4 2022 | 123 | $1.21B |
| Q3 2022 | 124 | $2.08B |
| Q2 2022 | 101 | $695.8M |
| Q1 2022 | 92 | $1.06B |
| Q4 2021 | 96 | $1.66B |
| Q3 2021 | 73 | $1.81B |
| Q2 2021 | 69 | $2.25B |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Verve Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 403,563 | $5.82M | 0.00% | +3,700+0.9% | Added |
| Citadel Advisors LLC | 424,862 | $6.13M | 0.01% | +388,028+1,053.5% | Added |
| Citigroup Inc | 494,019 | $7.12M | 0.01% | +328,340+198.2% | Added |
| Rock Springs Capital Management LP | 558,837 | $8.06M | 0.19% | 00.0% | Unchanged |
| BVF Inc | 650,000 | $9.37M | 0.34% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 803,501 | $11.6M | 3.01% | −5,160−0.6% | Reduced |
| Geode Capital Management, LLC | 885,771 | $12.8M | 0.00% | +38,038+4.5% | Added |
| Wellington Management Group LLP | 933,167 | $13.5M | 0.00% | +74,065+8.6% | Added |
| Redmile Group, LLC | 1,120,679 | $16.2M | 0.70% | −101,224−8.3% | Reduced |
| Novo Holdings A/S | 1,200,000 | $17.3M | 1.23% | +288,889+31.7% | Added |
| Avidity Partners Management LP | 1,351,700 | $19.5M | 0.65% | −213,300−13.6% | Reduced |
| Baker Bros. Advisors LP | 1,416,530 | $20.4M | 0.11% | 00.0% | Unchanged |
| Nikko Asset Management Americas, Inc. | 1,597,994 | $22.4M | 0.26% | +369,547+30.1% | Added |
| Sumitomo Mitsui Trust Holdings, Inc. | 1,597,994 | $23.0M | 0.02% | +369,547+30.1% | Added |
| JPMorgan Chase & Co | 1,908,364 | $27.5M | 0.00% | +119,902+6.7% | Added |
| T. Rowe Price Investment Management, Inc. | 2,006,127 | $28.9M | 0.02% | +206,477+11.5% | Added |
| ARCH Venture Management, LLC | 2,008,809 | $29.0M | 13.98% | 00.0% | Unchanged |
| Casdin Capital, LLC | 2,120,571 | $30.6M | 2.53% | −170,000−7.4% | Reduced |
| Federated Hermes, Inc. | 2,402,640 | $34.6M | 0.09% | +324,351+15.6% | Added |
| State Street Corp | 3,349,777 | $48.3M | 0.00% | −1,121,272−25.1% | Reduced |
| BlackRock Inc. | 3,546,485 | $51.1M | 0.00% | −47,589−1.3% | Reduced |
| Vanguard Group Inc | 3,878,850 | $55.9M | 0.00% | +66,826+1.8% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 4,482,091 | $64.6M | 0.44% | +116,261+2.7% | Added |
| FMR LLC | 6,826,817 | $98.4M | 0.01% | −78,606−1.1% | Reduced |
| Alphabet Inc. | 10,549,086 | $152.1M | 8.43% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −690,000−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −51,640−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −37,794−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −35,600−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −15,346−100.0% | Sold out |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −11,112−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Highlander Capital Management, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −213−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −71−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −4−100.0% | Sold out |